Caffeine exposure ameliorates acute ischemic cell death in avian developing retina.

Animals Caffeine / pharmacology Cell Death / drug effects Cell Hypoxia / drug effects Chick Embryo Chickens Ischemia / metabolism Neuroprotective Agents / pharmacology Retina / drug effects Signal Transduction / drug effects
BDNF Caffeine Ischemia KCC2 NMDA Retina

Journal

Purinergic signalling
ISSN: 1573-9546
Titre abrégé: Purinergic Signal
Pays: Netherlands
ID NLM: 101250499

Informations de publication

Date de publication:
03 2020
Historique:
received: 14 03 2019
accepted: 15 01 2020
pubmed: 23 2 2020
medline: 2 2 2021
entrez: 21 2 2020
Statut: ppublish

Résumé

In infants, the main cause of blindness is retinopathy of prematurity that stems in a hypoxic-ischemic condition. Caffeine is a psychoactive compound that at low to moderate concentrations, selectively inhibits adenosine A

Identifiants

DOI: 10.1007/s11302-020-09687-1 PMID: 32078115 PMC: PMC7166236
pubmed: 32078115
doi: 10.1007/s11302-020-09687-1
pii: 10.1007/s11302-020-09687-1
pmc: PMC7166236
doi:

Substances chimiques

Neuroprotective Agents 0
Caffeine 3G6A5W338E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-59

Références

Mol Pharmacol. 1992 Aug;42(2):210-6
pubmed: 1355259
Brain Res Dev Brain Res. 1992 Nov 20;70(1):87-95
pubmed: 1473280
Free Radic Biol Med. 2015 Feb;79:45-55
pubmed: 25486178
PLoS One. 2017 Jan 27;12(1):e0170545
pubmed: 28129361
J Neurocytol. 2001 Mar;30(3):181-93
pubmed: 11709625
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6625-32
pubmed: 20610844
J Mol Med (Berl). 2000;78(1):3-13
pubmed: 10759025
Food Chem Toxicol. 2012 Jun;50(6):1848-53
pubmed: 22449533
Eur J Neurosci. 2004 Sep;20(5):1197-204
pubmed: 15341591
Brain Res. 1994 Apr 4;641(2):217-24
pubmed: 8012824
J Alzheimers Dis. 2010;20 Suppl 1:S3-15
pubmed: 20164566
Neuron. 2012 Oct 18;76(2):266-80
pubmed: 23083731
Brain Res Bull. 2014 May;104:27-35
pubmed: 24727007
J Neurol Sci. 2009 Oct 15;285(1-2):39-45
pubmed: 19524941
Brain Res. 1995 Dec 24;705(1-2):79-84
pubmed: 8821736
Ann Neurol. 2006 Dec;60(6):696-705
pubmed: 17044013
Exp Eye Res. 2009 Mar;88(3):512-21
pubmed: 19084003
Brain Res. 2009 Nov 10;1297:185-93
pubmed: 19703429
Neurosci Lett. 1989 Sep 11;103(3):275-80
pubmed: 2812514
Br J Pharmacol. 2009 Jul;157(5):818-30
pubmed: 19422385
JAMA. 2000 May 24-31;283(20):2674-9
pubmed: 10819950
Neuroreport. 1998 Dec 1;9(17):3955-9
pubmed: 9875735
Pharmacol Rev. 2001 Dec;53(4):527-52
pubmed: 11734617
Am J Clin Nutr. 2010 Jun;91(6):1691-8
pubmed: 20427730
Transl Res. 2016 Mar;169:112-28
pubmed: 26685039
Exp Eye Res. 2013 Oct;115:206-15
pubmed: 23920155
Physiol Rev. 2007 Oct;87(4):1215-84
pubmed: 17928584
Pharmacol Rev. 1999 Mar;51(1):83-133
pubmed: 10049999
Trends Pharmacol Sci. 2000 Sep;21(9):341-6
pubmed: 10973087
J Matern Fetal Neonatal Med. 2014 Sep;27(14):1470-5
pubmed: 24392823
J Nutr Health Aging. 2014 Apr;18(4):383-92
pubmed: 24676319
Neurochem Int. 2001 Feb;38(2):107-25
pubmed: 11137880
Neuroscience. 2011 Apr 14;179:23-31
pubmed: 21277953
J Neurochem. 2016 Aug;138(4):557-70
pubmed: 27221759
J Cell Mol Med. 2014 Jun;18(6):1134-43
pubmed: 24636305
J Neurosci. 1999 Nov 1;19(21):9192-200
pubmed: 10531422
Pediatr Res. 1995 Sep;38(3):312-8
pubmed: 7494652
Brain Res. 2001 May 11;900(2):169-76
pubmed: 11334795
Neuroscience. 2016 Feb 9;314:145-59
pubmed: 26642806
Neurosci Lett. 1993 Dec 24;164(1-2):55-8
pubmed: 7908729
Prog Neurobiol. 2007 Apr;81(5-6):331-48
pubmed: 17303312
Brain Sci. 2013 Mar 05;3(1):177-90
pubmed: 24961313
Trends Pharmacol Sci. 1996 Mar;17(3):108-13
pubmed: 8936347
Exp Eye Res. 1988 May;46(5):657-62
pubmed: 2898379
Neurobiol Dis. 2007 Sep;27(3):354-61
pubmed: 17681771
J Cereb Blood Flow Metab. 2013 Oct;33(10):1612-20
pubmed: 23860373
Brain Res. 1999 May 8;827(1-2):79-92
pubmed: 10320696
Prog Retin Eye Res. 2004 Jan;23(1):91-147
pubmed: 14766318
Neuroscience. 2014 Oct 24;279:187-219
pubmed: 25168736
Exp Neurol. 2017 Sep;295:88-103
pubmed: 28576568
Mol Aspects Med. 2017 Jun;55:118-125
pubmed: 28088487
J Neuropathol Exp Neurol. 1999 Sep;58(9):972-81
pubmed: 10499439
J Neurosci. 2006 Apr 26;26(17):4509-18
pubmed: 16641230
Neuron. 1991 Mar;6(3):333-44
pubmed: 1672071
Neurol Sci. 2012 Apr;33(2):223-37
pubmed: 22044990
Sci Rep. 2017 Jan 18;7:40912
pubmed: 28098256
Nat Rev Neurosci. 2002 Sep;3(9):728-39
pubmed: 12209121
Teratog Carcinog Mutagen. 1994;14(5):205-11
pubmed: 7855740
Purinergic Signal. 2005 Jun;1(2):111-34
pubmed: 18404497
Stroke. 2008 Nov;39(11):3042-8
pubmed: 18688011
Neuroscience. 1991;42(1):171-82
pubmed: 1861772
Eur J Pharmacol. 1999 Sep 10;380(2-3):91-9
pubmed: 10513567
Public Health Nutr. 2016 May;19(7):1233-44
pubmed: 26329421
FASEB J. 2017 Aug;31(8):3334-3348
pubmed: 28420694
Eur J Pharmacol. 1996 Apr 29;302(1-3):43-8
pubmed: 8790990
Stroke. 2003 Mar;34(3):739-44
pubmed: 12624301
J Neurosci. 2001 Feb 1;21(3):897-910
pubmed: 11157076
J Neurochem. 1982 Feb;38(2):493-500
pubmed: 6180136
Brain Res. 2015 Jan 21;1595:10-8
pubmed: 25451122
N Engl J Med. 2007 Nov 8;357(19):1893-902
pubmed: 17989382
Invest Ophthalmol Vis Sci. 1994 Feb;35(2):685-95
pubmed: 7906683
Eur J Epidemiol. 2010 Apr;25(4):275-80
pubmed: 20306287
Am J Obstet Gynecol. 2008 Mar;198(3):279.e1-8
pubmed: 18221932
Pharmacol Toxicol. 1995 Nov;77(5):299-305
pubmed: 8778740
Brain Res Bull. 2015 Mar;112:1-6
pubmed: 25540918
Neuropharmacology. 1997 Sep;36(9):1327-38
pubmed: 9364488
Dev Dyn. 1992 Dec;195(4):231-72
pubmed: 1304821
Front Neurosci. 2014 Feb 27;8:40
pubmed: 24578682
CNS Neurosci Ther. 2017 Apr;23(4):272-290
pubmed: 28317317
Mol Neurobiol. 2016 May;53(4):2579-93
pubmed: 26081149
Hum Reprod. 2015 May;30(5):1246-55
pubmed: 25788567
An Acad Bras Cienc. 2010 Sep;82(3):595-608
pubmed: 21562688
Early Hum Dev. 2008 Feb;84(2):83-8
pubmed: 18234458
Neuroscience. 2014 Dec 5;281:208-15
pubmed: 25286387
Surv Ophthalmol. 1999 Jun;43 Suppl 1:S102-28
pubmed: 10416754
Arch Ophthalmol. 1975 Dec;93(12):1300-10
pubmed: 1200895
Eur J Epidemiol. 2014 Oct;29(10):725-34
pubmed: 25179792
J Neurosci. 1999 Mar 1;19(5):1657-62
pubmed: 10024352
Eur J Pharmacol. 1995 Dec 20;287(3):295-302
pubmed: 8991804
Nature. 1999 Jan 21;397(6716):251-5
pubmed: 9930699
J Neurosci Res. 1990 Feb;25(2):236-42
pubmed: 2157032
J Alzheimers Dis. 2010;20 Suppl 1:S25-34
pubmed: 20182030
PLoS One. 2012;7(3):e34278
pubmed: 22470550
Sci Transl Med. 2013 Aug 7;5(197):197ra104
pubmed: 23926202
Eur J Pharmacol. 1994 Apr 21;256(2):161-7
pubmed: 8050467
Vis Neurosci. 2010 Nov;27(5-6):149-57
pubmed: 20843408
Cell Death Dis. 2017 Oct 5;8(10):e3065
pubmed: 28981089
Brain Res. 2014 Mar 10;1551:59-72
pubmed: 24457041
Compr Physiol. 2016 Dec 6;7(1):113-170
pubmed: 28135002
Paediatr Perinat Epidemiol. 2006 Mar;20(2):100-9
pubmed: 16466428
Exp Neurol. 2012 Jan;233(1):193-204
pubmed: 22001157
Int J Mol Sci. 2018 Mar 09;19(3):
pubmed: 29522447
Neuropharmacology. 2016 May;104:105-30
pubmed: 26581499
Invest Ophthalmol Vis Sci. 1999 May;40(6):1200-16
pubmed: 10235554
Brain Res. 2003 Jan 10;959(2):243-50
pubmed: 12493612
PLoS One. 2015 Jul 20;10(7):e0132334
pubmed: 26193706
Int J Mol Sci. 2014 Jan 28;15(2):2024-52
pubmed: 24477263
Biochem Soc Trans. 2014 Apr;42(2):587-92
pubmed: 24646282
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
N Engl J Med. 2006 May 18;354(20):2112-21
pubmed: 16707748
Physiol Rev. 1999 Oct;79(4):1431-568
pubmed: 10508238

Auteurs

D Pereira-Figueiredo (D)

Neurobiology of the Retina Laboratory, Fluminense Federal University, Niterói, RJ, Brazil.
Laboratory of Neurochemistry, Department of Neurobiology and Program of Neurosciences, Fluminense Federal University, Niterói, RJ, Brazil.

R Brito (R)

Cellular Signaling and Metabolic Modulation Laboratory, Cellular and Molecular Biology Department, Institute of Biology, Fluminense Federal University, Niterói, RJ, Brazil.

D S M Araújo (DSM)

Neurobiology of the Retina Laboratory, Fluminense Federal University, Niterói, RJ, Brazil.
Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.

A A Nascimento (AA)

Neurobiology of the Retina Laboratory, Fluminense Federal University, Niterói, RJ, Brazil.
Laboratory of Neurochemistry, Department of Neurobiology and Program of Neurosciences, Fluminense Federal University, Niterói, RJ, Brazil.

E S B Lyra (ESB)

Fundamental and Applied Analytical Chemistry Laboratory (LAQAFA), Department of Analytical Chemistry, Chemistry Institute, Fluminense Federal University, Niterói, RJ, Brazil.

A M S S Cheibub (AMSS)

Fundamental and Applied Analytical Chemistry Laboratory (LAQAFA), Department of Analytical Chemistry, Chemistry Institute, Fluminense Federal University, Niterói, RJ, Brazil.

A D Pereira Netto (AD)

Fundamental and Applied Analytical Chemistry Laboratory (LAQAFA), Department of Analytical Chemistry, Chemistry Institute, Fluminense Federal University, Niterói, RJ, Brazil.

A L M Ventura (ALM)

Laboratory of Neurochemistry, Department of Neurobiology and Program of Neurosciences, Fluminense Federal University, Niterói, RJ, Brazil.
Neurobiology Department, Biology Institute of Fluminense Federal University, Niteroi, Rio de Janeiro, Brazil.

R Paes-de-Carvalho (R)

Laboratory of Cellular Neurobiology, Fluminense Federal University, Niterói, RJ, Brazil.
Laboratory of Neurochemistry, Department of Neurobiology and Program of Neurosciences, Fluminense Federal University, Niterói, RJ, Brazil.
Neurobiology Department, Biology Institute of Fluminense Federal University, Niteroi, Rio de Janeiro, Brazil.

K C Calaza (KC)

Neurobiology of the Retina Laboratory, Fluminense Federal University, Niterói, RJ, Brazil. kcalaza@id.uff.br.
Laboratory of Neurochemistry, Department of Neurobiology and Program of Neurosciences, Fluminense Federal University, Niterói, RJ, Brazil. kcalaza@id.uff.br.
Neurobiology Department, Biology Institute of Fluminense Federal University, Niteroi, Rio de Janeiro, Brazil. kcalaza@id.uff.br.
ORCID: 0000-0003-1199-1826

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Purines › Purinones › Xanthines › Caféine › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Mort cellulaire › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Respiration cellulaire › Hypoxie cellulaire › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Structures de l'embryon › Embryon non mammalien › Embryon de poulet › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Oiseaux › Poulets › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Ischémie › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Neuroprotecteurs › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Organes des sens › Oeil › Rétine › Caffeine exposure ameliorates acute ischemic...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Caffeine exposure ameliorates acute ischemic...